News
-
Dispensary Corner
Wednesday | May 16 2018
16 May 18TRAVELLERS needing "emotional support animals" to deal with anxiety when they fly on American Airlines may have to come up with a pharmaceutical solution instead.
-
Green Tea Scent Spray
Wednesday | May 16 2018ELIZABETH Arden Green Tea Scent Spray is an uplifting fragrance that energises the body, excites the senses and revitalises the spirits.
-
Daily Aloe Shampoo by Green People
Wednesday | May 16 2018GREEN People Daily Aloe Shampoo contains organic aloe vera and lavender.
-
Grahams Baby Body & Bath Oil
Wednesday | May 16 2018GRAHAMS Natural Baby Body & Bath Oil is a gentle, natural bath oil using avocado, jojoba, neem, sunflower and olive oil this bath oil is perfect for dry, sensitive and flaky skin.
-
Couture Brow – Brow Shaper Mascara
Wednesday | May 16 2018YVES Saint Laurent Couture Brow - Brow Shaper Mascara is a brow mascara that can be used to fix, structure and intensify the eyebrows for up to 24 hours.
-
NSW way behind on RTPM
Tuesday | May 15 2018AN admission last week by NSW's Chief Pharmacist that the state had no timetable for the introduction of a real time prescription monitoring (RTPM) system has shocked pharmacy officials.
-
MHR opt out date confirmed
Tuesday | May 15 2018THE Australian Digital Health Agency has announced that the three month "opt-out period" for the My Health Record system will run from 16 Jul-15 Oct 2018.
-
Trump plan to push down drug prices
Tuesday | May 15 2018US PRESIDENT Donald Trump has in part blamed foreign governments such as Australia that "extort unreasonably low prices from US drugmakers" for the high costs of prescription drugs in the US.
-
Slimming cap alert
Tuesday | May 15 2018THE Therapeutic Goods Administration has warned that a product labelled Lishou Strong Slimming Capsule contains the undeclared prescription-only substance sibutramine, which was withdrawn in 2010 after it showed increased risk of cardiac events.
-
FDA ticks kids MS Rx
Tuesday | May 15 2018THE US Food and Drug Administration has approved Gilenya (fingolimod) for the treatment of relapsing multiple sclerosis (MS) in children and adolescents aged 10 years & over.
